We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Rabbit Monoclonal Antibodies Developed for Immunohistochemistry Applications

By LabMedica International staff writers
Posted on 02 Mar 2010
Print article
A new range of rabbit monoclonal and polyclonal antibodies has been developed for immunohistochemistry (IHC) applications. A rabbit custom antibody service is also available.

Antibodies produced by rabbits are reported often to provide superior antigen recognition, greater specificity, and better consistency than those offered by mice. Rabbit antibodies can recognize specific antigens and epitopes that are not immunogenic in mice or rats. These antibodies can sometimes also offer higher working titers and may therefore help to lower laboratory costs. By using rabbit monoclonal antibodies (RMAbs), researchers can benefit from these unique qualities especially in the area of immunohistochemistry. Use of RMAbs technology provides critical information to researchers regarding the distribution and localization of biomarkers, and differentially expressed proteins in different parts of a biologic tissue.

AMSBIO (Abingdon, UK) offers a range of over 3,500 antibodies for immunohistochemistry including rabbit monoclonal, polyclonal, and mouse monoclonal antibodies (MAbs). Included in this range are antibodies that have been characterized to work on FFPE sections, renowned for their robust, highly sensitive, and specific characteristics. Many of these antibodies have been CE marked. The AMSBIO SP1 Estrogen Receptor antibody is now recommended as the gold standard by leading breast cancer experts and distributed worldwide.

AMS Biotechnology (AMSBIO) is a leading international provider of products and custom services for life sciences research. The AMSBIO range includes over 23,000 polyclonal and monoclonal antibodies, peptides, recombinant proteins, extracellular matrix, molecular detection reagents, tissue DNA, RNA, protein, and microarray products. Key research areas include apoptosis, cell invasion and migration, cell signaling, DNA damage, electrophoresis, glycobiology, posttranslational modification, and stem cell biology.

Related Links:

AMSBIO


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Automated Blood Typing System
IH-500 NEXT
New
Auto-Chemistry Analyzer
CS-1200
New
Tabletop Centrifuge
Mikro 185

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.